Immunotech Biopharm Ltd (HKG:6978)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
2.950
-0.050 (-1.67%)
Jun 24, 2025, 3:53 PM HKT
-5.75%
Market Cap 1.54B
Revenue (ttm) n/a
Net Income (ttm) -198.91M
Shares Out 514.58M
EPS (ttm) -0.39
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 662,000
Average Volume 437,800
Open 2.970
Previous Close 3.000
Day's Range 2.950 - 3.020
52-Week Range 1.500 - 6.150
Beta 0.86
RSI 39.43
Earnings Date Aug 22, 2025

About Immunotech Biopharm

Immunotech Biopharm Ltd, a cellular immunotherapy biopharmaceutical company, focuses on the research, development, and commercialization of T cell immunotherapy products for the treatment of cancers in the People’s Republic of China. The company’s core product is EAL, a multi-target cellular immunotherapy product that is in Phase III clinical trials for the prevention of postsurgical recurrence of liver cancer. It also develops 6B11-OCIK injection that is in Phase I clinical trial for ovarian cancer; CAR-T-19 injection product for B-cell acute ... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2006
Employees 154
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 6978
Full Company Profile

Financial Performance

Financial numbers in CNY Financial Statements

News

There is no news available yet.